Hui Liu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 17

Top Topics

Dna Methylation

Respiratory Syndrome Coronavirus

Regulatory T Cells

Top Venues

Cancer communications (London, England)

Signal transduction and targeted therapy

Clinical and translational medicine

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Zhihui Dai, Sijie Wang, Xinggang Guo, Yuefan Wang, Haozan Yin, Jian Tan, Chenyang Mu, Shu-Han Sun, Hui Liu, Fu Yang
Gender dimorphism in hepatocarcinogenesis-DNA methylation modification regulated X-chromosome inactivation escape molecule XIST. Clinical and translational medicine 13 (12) (2024)
Zhihui Dai, Sijie Wang, Xinggang Guo, Yuefan Wang, Haozan Yin, Jian Tan, Chenyang Mu, Shu-Han Sun, Hui Liu, Fu Yang
Gender dimorphism in hepatocarcinogenesis-DNA methylation modification regulated X-chromosome inactivation escape molecule XIST. Clinical and translational medicine 13 (12) (2024)
Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Yue-Fan Wang, Wen-Li Zhang, Zhi-Xuan Li, Yue Liu, Jian Tan, Hao-Zan Yin, Zhi-Chao Zhang, Xian-Jie Piao, Min-Hao Ruan, Zhi-Hui Dai, Si-Jie Wang, Chen-Yang Mu, Ji-Hang Yuan, Shu-Han Sun, Hui Liu, Fu Yang
METTL14 downregulation drives S100A4 + monocyte-derived macrophages via MyD88/NF-κB pathway to promote MAFLD progression. Signal transduction and targeted therapy 9 (1) (2024)
Zhihui Dai, Sijie Wang, Xinggang Guo, Yuefan Wang, Haozan Yin, Jian Tan, Chenyang Mu, Shu-Han Sun, Hui Liu, Fu Yang
Gender dimorphism in hepatocarcinogenesis-DNA methylation modification regulated X-chromosome inactivation escape molecule XIST. Clinical and translational medicine 13 (12) (2023)
Zhihui Dai, Sijie Wang, Xinggang Guo, Yuefan Wang, Haozan Yin, Jian Tan, Chenyang Mu, Shu-Han Sun, Hui Liu, Fu Yang
Gender dimorphism in hepatocarcinogenesis-DNA methylation modification regulated X-chromosome inactivation escape molecule XIST. Clinical and translational medicine 13 (12) (2023)
Fuchen Liu, Xiaochen Feng, Jin Du, Minghao Ruan, Hui Liu
Serologic status and safety of inactivated Covid-19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection. Cancer communications (London, England) 43 (3) (2022)
Fuchen Liu, Xiaochen Feng, Jin Du, Minghao Ruan, Hui Liu
Serologic status and safety of inactivated Covid-19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection. Cancer communications (London, England) (2022)
Fuchen Liu, Xiaochen Feng, Jin Du, Minghao Ruan, Hui Liu
Serologic status and safety of inactivated Covid-19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection. Cancer communications (London, England) 43 (3) (2022)
Fuchen Liu, Wenli Zhang, Hui Liu
Letter to the editor: Hepatocyte proliferation peak and β-oxidation in liver regeneration after partial hepatectomy. Hepatology (Baltimore, Md.) 75 (5) (2022)
Fuchen Liu, Xiaochen Feng, Jin Du, Minghao Ruan, Hui Liu
Serologic status and safety of inactivated Covid-19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection. Cancer communications (London, England) (2022)
Guojun Hou, Wenfang Xu, Dongyang Ding, Tao Tian, Gang Liu, Yuan Yang, Hui Liu, Weiping Zhou
Metabolome and transcriptome integration reveals metabolic profile of hepatocellular carcinoma. Journal of gastroenterology and hepatology (2022)
Fuchen Liu, Xiaochen Feng, Jin Du, Minghao Ruan, Hui Liu
Serologic status and safety of inactivated Covid-19 vaccine for hepatocellular carcinoma patients with cirrhosis after curative liver resection. Cancer communications (London, England) 43 (3) (2022)
Wen-Bin Ding, Meng-Chao Wang, Jian Yu, Gang Huang, Da-Peng Sun, Lei Liu, Jia-Ning Zhang, Yuan Yang, Hui Liu, Wei-Ping Zhou, Fu Yang, Sheng-Xian Yuan
HBV/Pregenomic RNA Increases the Stemness and Promotes the Development of HBV-Related HCC Through Reciprocal Regulation With Insulin-Like Growth Factor 2 mRNA-Binding Protein 3. Hepatology (Baltimore, Md.) 74 (3) (2021)